Neuroone Historical Income Statement
| NMTC Stock | USD 0.76 0.02 2.70% |
Historical analysis of Neuroone Medical income statement accounts such as Gross Profit of 1.1 M can show how well Neuroone Medical Technologies performed in making a profits. Evaluating Neuroone Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Neuroone Medical's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Neuroone Medical Tec latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Neuroone Medical Tec is a good buy for the upcoming year.
Neuroone |
About Neuroone Income Statement Analysis
Neuroone Medical Tec Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Neuroone Medical shareholders. The income statement also shows Neuroone investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Neuroone Medical Income Statement Chart
Add Fundamental
Interest Expense
The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Neuroone Medical Tec. It is also known as Neuroone Medical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Neuroone Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Neuroone Medical Tec current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neuroone Medical Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. At present, Neuroone Medical's Total Revenue is projected to increase significantly based on the last few years of reporting. The current year's Gross Profit is expected to grow to about 1.1 M, whereas Interest Expense is forecasted to decline to about 217.5 K.
Neuroone Medical income statement Correlations
Click cells to compare fundamentals
Neuroone Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Neuroone Medical income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 284.6K | 7.5M | 3.1K | 31.2K | 229.0K | 217.5K | |
| Selling General Administrative | 4.8M | 6.3M | 6.7M | 6.8M | 7.9M | 8.3M | |
| Total Revenue | 1.9M | 178.1K | 171.2K | 2.0M | 3.5M | 3.6M | |
| Gross Profit | 63.1K | (97.7K) | (70.8K) | 456.5K | 1.1M | 1.1M | |
| Other Operating Expenses | 4.9M | 10.4M | 10.2M | 13.9M | 15.3M | 16.1M | |
| Operating Income | (4.9M) | (10.2M) | (10.0M) | (12.0M) | (11.9M) | (11.3M) | |
| Ebit | (4.9M) | (9.9M) | (10.1M) | (12.0M) | (12.1M) | (11.5M) | |
| Ebitda | (4.9M) | (9.8M) | (9.9M) | (11.8M) | (11.8M) | (11.3M) | |
| Total Operating Expenses | 4.9M | 10.1M | 10.0M | 12.4M | 13.0M | 13.6M | |
| Income Before Tax | (13.6M) | (9.9M) | (10.0M) | (11.9M) | (12.3M) | (11.7M) | |
| Net Income | (13.6M) | (9.9M) | (10.0M) | (11.9M) | (12.3M) | (11.7M) | |
| Cost Of Revenue | 1.9M | 275.9K | 242.0K | 1.5M | 2.4M | 2.5M | |
| Total Other Income Expense Net | (8.7M) | 270.0K | 31.2K | 95.8K | (430.9K) | (452.4K) | |
| Depreciation And Amortization | 70.6K | 147.1K | 226.2K | 199.3K | 246.8K | 259.1K | |
| Net Income From Continuing Ops | (13.6M) | (9.9M) | (10.0M) | (11.9M) | (12.3M) | (11.7M) | |
| Research Development | 2.1M | 3.9M | 4.9M | 6.9M | 5.1M | 2.9M | |
| Net Income Applicable To Common Shares | (6.8M) | (13.6M) | (9.9M) | (10.0M) | (9.0M) | (9.4M) | |
| Income Tax Expense | 7.5M | 274.2K | (109.9K) | 31.4K | 36.1K | 34.3K | |
| Reconciled Depreciation | 47.6K | 80.7K | 118.6K | 199.3K | 246.8K | 259.1K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Neuroone Medical Tec offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Neuroone Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neuroone Medical Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neuroone Medical Technologies Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neuroone Medical Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuroone Medical. If investors know Neuroone will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuroone Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.46) | Revenue Per Share 0.158 | Quarterly Revenue Growth 0.311 | Return On Assets (1.43) | Return On Equity (3.49) |
The market value of Neuroone Medical Tec is measured differently than its book value, which is the value of Neuroone that is recorded on the company's balance sheet. Investors also form their own opinion of Neuroone Medical's value that differs from its market value or its book value, called intrinsic value, which is Neuroone Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuroone Medical's market value can be influenced by many factors that don't directly affect Neuroone Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuroone Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuroone Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuroone Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.